نتایج جستجو برای: hiv 1 pr

تعداد نتایج: 2909370  

2016
Rushi V. Parikh Yifei Ma Rebecca Scherzer Amanda S. Heringer John S. Macgregor Jeffrey N. Martin Steven G. Deeks Peter Ganz Priscilla Y. Hsue James West

BACKGROUND HIV infection is an independent risk factor for PAH, but the underlying pathogenesis remains unclear. ET-1 is a robust vasoconstrictor and key mediator of pulmonary vascular homeostasis. Higher levels of ET-1 predict disease severity and mortality in other forms of PAH, and endothelin receptor antagonists are central to treatment, including in HIV-associated PAH. The direct relations...

2010
Luis Menéndez-Arias

The retroviral RNA genome encodes for three enzymes essential for virus replication: (i) the viral protease (PR), that converts the immature virion into a mature virus through the cleavage of precursor polypeptides; (ii) the reverse transcriptase (RT), responsible for the conversion of the single-stranded genomic RNA into double-stranded proviral DNA; and (iii) the integrase (IN) that inserts t...

Journal: :Journal of virology 2013
Kirsten M Stray Christian Callebaut Bärbel Glass Luong Tsai Lianhong Xu Barbara Müller Hans-Georg Kräusslich Tomas Cihlar

GS-8374 is a potent HIV protease inhibitor (PI) with a unique diethyl-phosphonate moiety. Due to a balanced contribution of enthalpic and entropic components to its interaction with the protease (PR) active site, the compound retains activity against HIV mutants with high-level multi-PI resistance. We report here the in vitro selection and characterization of HIV variants resistant to GS-8374. ...

2014
Sameshnee Kelly Pillay Urisha Singh Avashna Singh Michelle Gordon Thumbi Ndungu

The development of antiretroviral (ARV) drugs and their use in human immunodeficiency virus type 1 (HIV-1) has led to the effective control of HIV replication in infected patients. However the emergence of resistant HIV-1 strains still remains a problem. Literature has shown that mutations may accumulate in the protease (PR) and gag regions of HIV-1 patients who fail therapy with protease inhib...

Journal: :Journal of virology 1993
J Luban C Lee S P Goff

We have expressed the human immunodeficiency virus type 1 (HIV-1) protease (PR) in bacteria as a Gag-PR polyprotein (J. Luban and S.P. Goff, J. Virol. 65:3203-3212, 1991). The protein displays enzymatic activity, cleaving the Gag polyprotein precursor Pr55gag to the expected products. The PR enzyme is only active as a dimer, and we hypothesized that PR activation might be used as an indicator o...

Journal: :European respiratory review : an official journal of the European Respiratory Society 2009
S Bloch M Wickremasinghe A Wright A Rice M Thompson O M Kon

Paradoxical reaction (PR) in tuberculosis (TB) is common and may affect up to 25% of patients. PR has the potential to cause significant morbidity and, on occasion, death. Although PR has been recognised for some time, the pathophysiology, especially in HIV-negative patients, is not well understood. We present two cases of PR in HIV-negative patients with TB presenting as significant airway obs...

2017
Ekaterine Karkashadze Margaret A. Gates Nikoloz Chkhartishvili Jack DeHovitz Tengiz Tsertsvadze

The purpose of our study was to assess quality of life (QoL) among Georgian HIV-infected individuals and to examine factors associated with QoL. Our cross-sectional study sample consisted of 201 HIV-infected adult outpatients recruited at the National AIDS Center in Tbilisi, Georgia. WHOQOL-HIV-BREF was used to measure QoL. Data about other variables of interest were obtained from medical recor...

2003
Kwan H. Lee

-A pharmacophore derived from the structure of the dithiolane derivative of haloperidol bound in the active site of the HIV-1 protease (HIV-1 PR) has been used to search a three-dimensional database for new inhibitory frameworks. This search identified an FMOC-protected N-tosyl arginine as a lead candidate. A derivative in which the arginine carboxyl has been converted to an amide has been crys...

2014
Giovanna Rappocciolo Mariel Jais Paolo Piazza Todd A. Reinhart Stella J. Berendam Laura Garcia-Exposito Phalguni Gupta Charles R. Rinaldo

ABSTRACT HIV-1-infected nonprogressors (NP) inhibit disease progression for years without antiretroviral therapy. Defining the mechanisms for this resistance to disease progression could be important in determining strategies for controlling HIV-1 infection. Here we show that two types of professional antigen-presenting cells (APC), i.e., dendritic cells (DC) and B lymphocytes, from NP lacked t...

2015
Karin Neukam Daniela I. Munteanu Antonio Rivero-Juárez Thomas Lutz Jan Fehr Mattias Mandorfer Sanjay Bhagani Luis F. López-Cortés Annette Haberl Marcel Stoeckle Manuel Márquez Stefan Scholten Ignacio de los Santos-Gil Stefan Mauss Antonio Rivero Antonio Collado Marcial Delgado Juergen K. Rockstroh Juan A. Pineda

BACKGROUND AND AIMS Clinical trials of therapy against chronic hepatitis C virus (HCV) infection including boceprevir (BOC) or telaprevir (TVR) plus pegylated interferon and ribavirin (PR) have reported considerably higher response rates than those achieved with PR alone. This study sought to evaluate the efficacy and safety of triple therapy including BOC or TVR in combination with PR in HIV/H...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید